Harvest Group Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Harvest Group Wealth Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-184	Closed	-$18K	–	289
2020 Q4	$18K	Hold	184	–	–	0.01%	181
2020 Q3	$26K	Hold	184	–	–	0.02%	146
2020 Q2	$36K	Buy	184 +30	+19%	+$6.21K	0.03%	102
2020 Q1	$30K	Hold	154	–	–	0.03%	104
2019 Q4	$31K	Hold	154	–	–	0.03%	110
2019 Q3	$24K	Hold	154	–	–	0.03%	140
2019 Q2	$19K	Buy	154 +17	+12%	+$2.02K	0.02%	157
2019 Q1	$16K	Buy	+137	New	+$13.8K	0.01%	186

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Harvest Group Wealth Management's LKFT Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 184 shares — an estimated $18K sold.

Harvest Group Wealth Management first reported a position in LKFT in Q1 2019 and held it in 8 quarters. The position peaked at $36K in Q2 2020. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

Harvest Group Wealth Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Harvest Group Wealth Management sold 184 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $18K.
Harvest Group Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 8 quarters.
Harvest Group Wealth Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $36K in Q2 2020.
132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.